Physician profile
Eric Chan
NPI 1336539048
$5,039.84
in general payments reported to CMS, 2019-2025
22 companies · $2,126 in 2025
The $2,126 reported for 2025 was more than what 81% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $179 · 2023: $2,439 · 2024: $296 · 2025: $2,126.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,612 · Food and Beverage: $1,249.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,612.33 |
| Food and Beverage | $1,248.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $2,232.56 | 2023 | Axonics, Bulkamid |
| Intuitive Surgical, INC. | $1,695.28 | 2025 | |
| Royal Biologics, INC. | $167.46 | 2025 | |
| Janssen Biotech, INC. | $150.37 | 2024-2025 | Erleada, Akeega, Balversa |
| Abbvie INC. | $141.06 | 2022-2023 | Botox |
| Bayer Healthcare Pharmaceuticals INC. | $134.59 | 2022-2025 | |
| Hollister Incorporated | $120.45 | 2022-2024 | Vapro Pocket, Vapro Plus Pocket |
| Dendreon Pharmaceuticals LLC | $69.59 | 2024-2025 | Provenge |
| Telix Pharmaceuticals | $51.34 | 2023-2025 | Illuccix |
| Olympus America INC. | $40.14 | 2024-2025 | Itind System |
| Progenics Pharmaceuticals, INC. | $28.77 | 2025 | |
| Tolmar, INC. | $28.33 | 2023 | |
| Conmed Corporation | $27.84 | 2024 | Airseal |
| 180 Medical, INC. | $26.87 | 2022 | |
| Palette Life Sciences, INC. | $20.46 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $19.94 | 2025 | |
| Astellas Pharma US INC | $17.00 | 2023 | Myrbetriq |
| Urogen Pharma, INC. | $16.22 | 2023 | Jelmyto |
| Sumitomo Pharma America, INC. | $14.82 | 2025 | Orgovyx |
| Davol INC. | $13.58 | 2025 | Aptra |
| Boston Scientific Corporation | $13.17 | 2023 | Rezum Generator |
| Escala Medical INC. | $10.00 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Chan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.